35Pharma Inc: Clinical Trials

3 trials sponsored by 35Pharma Inc, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Terminated 2, Completed 1

Follow 35Pharma Inc: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of HS135 in Obese Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction
HS135, Placebo - Heart Failure With Preserved Ejection Fraction, Pulmonary Hypertension
Phase 1Terminated35Pharma Inc42025-01-232025-09-04
Study of HS235 for Assessing the Pharmacokinetics, Safety, and Pharmacodynamics in Overweight/Obese Healthy Subjects
HS235, Placebo - Overweight and Obesity
Phase 1Completed35Pharma Inc392024-11-282025-12-30
A Study of HS135 for the Treatment of Pulmonary Arterial Hypertension in Adults
HS135 - Pulmonary Arterial Hypertension (PAH)
Phase 1Terminated35Pharma Inc52024-10-232025-05-30

Conditions studied

Hypertension, Pulmonary (1)  ·  Obesity (1)  ·  Overweight (1)  ·  Pulmonary Arterial Hypertension (1)

Countries

Canada (2)  ·  Germany (1)  ·  United States (1)

Top investigators

Monique Champagne, M.Sc. (3)